SAMPLE. Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline
|
|
- Chad Dennis
- 5 years ago
- Views:
Transcription
1 October 2009 Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline This guideline outlines the recommended protocols for screening preterm, sick, or low birth weight infants for hearing loss and disorders detectable through dried blood spot testing. A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.
2 Clinical and Laboratory Standards Institute Setting the standard for quality in clinical laboratory testing around the world. The Clinical and Laboratory Standards Institute (CLSI) is a not-for-profit membership organization that brings together the varied perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: to foster excellence in laboratory medicine by developing and implementing clinical laboratory standards and guidelines that help laboratories fulfill their responsibilities with efficiency, effectiveness, and global applicability. Consensus Process Consensus the substantial agreement by materially affected, competent, and interested parties is core to the development of all CLSI documents. It does not always connote unanimous agreement, but does mean that the participants in the development of a consensus document have considered and resolved all relevant objections and accept the resulting agreement. Commenting on Documents CLSI documents undergo periodic evaluation and modification to keep pace with advancements in technologies, procedures, methods, and protocols affecting the laboratory or health care. CLSI s consensus process depends on experts who volunteer to serve as contributing authors and/or as participants in the reviewing and commenting process. At the end of each comment period, the committee that developed the document is obligated to review all comments, respond in writing to all substantive comments, and revise the draft document as appropriate. Comments on published CLSI documents are equally essential, and may be submitted by anyone, at any time, on any document. All comments are addressed according to the consensus process by a committee of experts. Appeals Process If it is believed that an objection has not been adequately addressed, the process for appeals is documented in the CLSI Administrative Procedures. All comments and responses submitted on draft and published documents are retained on file at CLSI and are available upon request. Get Involved Volunteer! Do you use CLSI documents in your workplace? Do you see room for improvement? Would you like to get involved in the revision process? Or maybe you see a need to develop a new document for an emerging technology? CLSI wants to hear from you. We are always looking for volunteers. By donating your time and talents to improve the standards that affect your own work, you will play an active role in improving public health across the globe. For further information on committee participation or to submit comments, contact CLSI. Clinical and Laboratory Standards Institute 950 West Valley Road, Suite 2500 Wayne, PA USA P: F: standard@clsi.org
3 ISBN Vol. 29 No. 24 Formerly I/LA31-A ISSN Vol. 29 No. 24 Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline Volume 29 Number 24 Julie Miller, BS Judith Tuerck, MS, BS, RN Khalid Awad, MD Donald H. Chace, PhD, MSFS Sara Copeland, MD Abstract Sonja A. Rasmussen, MD, MS Leanne Rien, RN, BS Christina J. Valentine, MD, MS, RD Dianne R. Webster, PhD, FHGSA Bridget Wilcken, MBChB, FRACP, FRCPA Clinical and Laboratory Standards Institute document Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline addresses newborn screening of preterm, low birth weight (LBW), and sick newborns worldwide to detect treatable conditions before physical damage can occur to the infant. In developed countries, advances in the treatment they receive have improved survival rates, making the early detection of conditions detected by newborn screening even more important. The physiological states associated with preterm, LBW, and sick newborns, and the treatments they receive, directly affect the reliability of results for many conditions screened in public health dried blood spot and newborn hearing screening systems. This guideline describes the effects of maternal and infant conditions, as well as treatments given to newborns. It also provides the rationale for the recommended intervals for screening designed to minimize the risk of missing or delaying a diagnosis in an affected newborn. It is intended for use by those involved in any aspect of newborn screening specimen collection or hearing screening testing and follow-up, including health care providers, parents, public health professionals, and others concerned with the health and welfare of newborns. Clinical and Laboratory Standards Institute (CLSI). Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline. CLSI document (ISBN ). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania USA, The Clinical and Laboratory Standards Institute consensus process, which is the mechanism for moving a document through two or more levels of review by the health care community, is an ongoing process. Users should expect revised editions of any given document. Because rapid changes in technology may affect the procedures, methods, and protocols in a standard or guideline, users should replace outdated editions with the current editions of CLSI documents. Current editions are listed in the CLSI catalog and posted on our website at If your organization is not a member and would like to become one, and to request a copy of the catalog, contact us at: Telephone: ; Fax: ; customerservice@clsi.org; Website:
4 Number 24 Copyright 2009 Clinical and Laboratory Standards Institute. Except as stated below, any reproduction of content from a CLSI copyrighted standard, guideline, companion product, or other material requires express written consent from CLSI. All rights reserved. Interested parties may send permission requests to permissions@clsi.org. CLSI hereby grants permission to each individual member or purchaser to make a single reproduction of this publication for use in its laboratory procedure manual at a single site. To request permission to use this publication in any other manner, permissions@clsi.org. Suggested Citation CLSI. Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline. CLSI document. Wayne, PA: Clinical and Laboratory Standards Institute; Proposed Guideline December 2008 Approved Guideline October 2009 ISBN ISSN ii
5 Volume 29 Contents Abstract... i Committee Membership... iii Foreword... vii 1 Scope Introduction Standard Precautions Terminology A Note on Terminology Definitions Abbreviations and Acronyms General Considerations Maternal Conditions and Treatment and Their Effects on Newborn Screening Results Thyroid Dysfunction Steroids Maternal and Infant Conditions Detectable by Tandem Mass Spectrometry Effects of Preterm Birth and Special Care Baby Unit Interventions on Newborn Screening Routine Special Care Baby Unit Interventions Disorders on Screening Panels Cystic Fibrosis Congenital Hypothyroidism Urea Cycle Defects, Organic Acidemias, and Aminoacidopathies Fatty Acid Oxidation Defects Enzymopathies: Galactosemia and Biotinidase Deficiency Sickle Cell Disease and Hemoglobinopathies Difficulties With Current Special Care Baby Unit Protocols for Newborn Screening Pretreatment Screening General Recommendations for Blood Spot Screening of Preterm, Low Birth Weight, and Sick Infants Blood Spot Screening Primary Recommendation On Admission to the Special Care Baby Unit for Blood Spot Testing Day of Life 48 to 72 Hours Day of Life Alternative Recommendation for Blood Spot Collection Timing Admission to the Special Care Baby Unit After 24 to 48 Hours of Life or Pretransfusion, Preparenteral Nutrition Recommendations for Special Care Baby Unit Infants Not Screened as Recommended Special Considerations for Timing of Blood Specimen Collection (in the Event of Deviation From Established Protocols) v
6 Number 24 Contents (Continued) 12 Hearing Screening for Special Care Baby Unit Infants Risk Factors for Hearing Loss in the Special Care Baby Unit Special Circumstances Related to the Special Care Baby Unit Roles of the Newborn Screening Follow-up Evaluation and Quality Assurance Research Opportunities and Education References Appendix A. Summary of Factors in Preterm/Sick Infants Affecting Reliability of Newborn Screening Results Appendix B. Summary of Conditions Included on Screening Panels Summary of Delegate Comments and Subcommittee Responses The Quality Management System Approach Related CLSI Reference Materials vi
7 Volume 29 Foreword There are approximately 127 million births per year worldwide. 1 In the United States, in million infants were born, and 8.2% of those infants were low birth weight, 12.7% were preterm (< 37 weeks gestation), and 3% were born with birth defects. 2 In developed and developing countries, these infants are usually cared for in specially equipped wards or units such as special care baby units (SCBUs) sometimes referred to as neonatal intensive care units (NICUs). For the purpose of this document, SCBU is used to represent these levels of nursery care. Preterm birth is defined as a gestational age of less than 37 completed weeks and low birth weight (LBW) as less than 2500 g. In some countries, approximately 25% of infants are less than this weight and may or may not be considered candidates in need of the specialized care. Tremendous advances in the care of preterm infants have resulted in improved survivability for increasingly smaller and more preterm infants. Today in developed countries, infants of 28 weeks gestation or older have a > 96% chance of survival, with the lower limits of viability at about 22 weeks, with only 2% of these infants surviving. 2 Newborn screening (NBS) systems and laboratory technology have evolved as well, with the addition of isoelectric focusing and high-performance liquid chromatography for hemoglobinopathies, enzyme assays for biotinidase deficiency and galactosemia, DNA analysis for cystic fibrosis and hemoglobinopathy screening, and tandem mass spectrometry (MS/MS) for metabolic disorders and other multiplex screening tests. It is now possible to screen for a large number of conditions. As of 2008, more than 50 conditions are included in blood spot screening panels in some NBS programs. 3 In addition, most infants are now screened for hearing loss before discharge from the birth facility. Including hearing screening, the collective incidence of disorders for which NBS is available is 1:250 infants compared with 1:3000 only 10 years ago. 4 New tests for additional conditions are under development, undergoing pilot testing, or both in many parts of the world. With the pace of technologic and therapeutic advances, it is certain that more conditions will be added to NBS panels in the future. As more conditions are added, it becomes increasingly difficult to advise practitioners about the ideal time to collect an NBS specimen. Each condition has its own best screening window when there is the greatest chance of diagnosing and treating the disorder in question before symptoms or permanent damage occurs. Some conditions, such as maple syrup urine disease (MSUD), galactosemia, and congenital adrenal hyperplasia, have very short screening windows, with abnormal analytes present in the first day or so of life, illness beginning by the end of the first week, and death in the second week if not diagnosed. Therefore, the best time to collect specimens for those disorders that necessitate early treatment is in the first 24 to 48 hours, and specimens collected after four days may be too late to prevent death or damage. Other conditions, such as homocystinuria, are difficult to detect on a specimen collected in the first 24 to 48 hours of life because the analyte currently used in many programs, methionine, rises very slowly in affected infants and may not be elevated for several days to a week. Likewise, in some infants with congenital hypothyroidism, the decline in thyroid hormone (thyroxine T4) and rise in thyroid-stimulating hormone (thyrotropin TSH), analytes commonly used to detect the condition, may not occur for several days (or longer) if the infant has a large ectopic gland producing sufficient T4 to suppress TSH production at birth. Because maturation of the hypothalamic-pituitary axis at birth is insufficient to produce TSH in very low birth weight (VLBW) infants, these infants with hypothyroidism often have low or normal TSH levels at birth and may not be identified on a screening specimen collected at less than one week of age. 5 Specimen collection timing varies around the world; in Europe and Australia-Asia, most specimens are collected at 48 to 72 hours of age; in the United States, before 48 hours of age; and in Great Britain, infants are not screened until the fifth to eighth day of life. 6 No published data on age at collection were found for the Latin American or Middle East/South African regions. Unfortunately, SCBU infants are at greater risk for missed or incomplete NBS than normal newborns owing to the focus on the critical activities surrounding their care, their pre- and postnatal environments, vii
8 Number 24 the treatments given to them, and the unique genetic and biochemical nature of the infants themselves. These factors can negatively affect both the quality and validity of the screening results for many of the disorders included in NBS panels. As a result, SCBU infants are much more likely to have false-positive or false-negative results after NBS and thus, they account for a disproportionate follow-up effort, compared with normal newborns. Preterm, LBW, or sick term infants often have multiple NBSs and diagnostic specimens collected in an attempt to clarify the significance of an out-of-range result. At the other extreme, collection of NBS specimens can be overlooked in the complexity of activities that occur in the SCBU. These factors increase the chance that a newborn requiring SCBU care will not have a condition detectable by NBS identified in a timely manner, with potentially catastrophic results. 7-9 Although a few case reports have documented the presence of this problem, studies assessing its magnitude have not been performed. During the development of this guideline, experts in neonatology, NBS, endocrinology, metabolism, hematology, hearing loss, genetics, and cystic fibrosis worked collectively to outline factors that interfere with the reliability of NBS, review the significance and duration of the interference, and provide recommendations for NBS specimen collection, including information on timing and number of specimens. This guideline is in agreement with existing consensus guidelines, including those from CLSI (see CLSI documents I/LA27 10 and LA04 11 ) and various neonatology organizations This guideline provides reference for NBS programs and SCBUs to develop and provide screening, testing and followup protocols. The goal is to complete NBS for every SCBU infant in the shortest period of time, with the highest degree of reliability and using the fewest number of specimens. It is hoped that individual NBS programs will adopt this guideline to standardize procedures for intensive care practitioners, and most important, to improve the quality of NBS and follow-up for all infants in their jurisdictions. Key Words Best practices, congenital anomalies, low birth weight, newborn hearing screening, newborn screening, preterm birth, sick infants, special care baby unit viii
9 Volume 29 Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline 1 Scope This guideline addresses best practices for SCBU personnel, as well as primary health care providers, laboratory, and follow-up personnel to provide all preterm, LBW, and sick infants with valid newborn blood spot and hearing screening. Best practices are defined with consideration of the conditions screened for and timing of screening events. Special circumstances include the condition of the infant, treatments given, maternal conditions/therapies, and other factors. This document does not intend to dictate SCBU care practices. Goals of this guideline are to 1) Ensure rapid, consistent, and complete blood spot and hearing screening, including appropriate follow-up to ensure early diagnosis and treatment for preterm, LBW, or sick newborns affected with a screened condition. 2) Minimize the risk of a missed or delayed diagnosis and treatment for all screened conditions. 3) Optimize the timing and minimize the number of blood spot specimen collections and hearing screening events. 4) Define essential elements of quality assurance relevant to this guideline. 5) Provide education on the effects of SCBU treatments on newborn blood spot and hearing screening. 6) Identify areas needing further research. 2 Introduction This guideline is a part of a series produced by CLSI over the last several years that includes related CLSI documents LA04 11 and I/LA These documents provide more detail regarding the structure and function of specific elements of NBS systems, and this information is not duplicated here, except for a discussion of proposed reporting and follow-up algorithms. This document focuses on treatments and practices within the SCBU and neonatal conditions that are either known or suspected to interfere with valid NBS, the consequences of the interference, and recommendations for avoiding or counteracting these problems. Care and treatment of preterm, LBW, and sick infants and improvements to NBS programs have made great advancements, but little is known as to the impact of one on the other. The effects of preterm birth and its associated treatment are partially understood for certain disorders on NBS panels, for example, endocrine disorders, hemoglobinopathies, enzymopathies such as galactosemia, and cystic fibrosis (CF). However, very little is known about most metabolic disorders. Simple questions such as how long parenteral nutrition (PN) affects results on amino acid tests are unknown at this time, and this document reflects areas where no data exist. Further research is urgently needed. Because no test has been proven to produce results consistently with 100% sensitivity and specificity, including those used in NBS, practitioners should be reminded to remain vigilant for signs and symptoms associated with screened conditions, even in the presence of normal NBS results. Clinical and Laboratory Standards Institute. All rights reserved. 1
10 Number 24 Beyond individual case reports, the number of affected SCBU infants missed because of incomplete or no screening is unknown. Any missed case, however, represents a failure of the system and a double tragedy for the infant and family, who have already endured the rigors of survival for preterm birth, LBW, or other neonatal illness and now must face lifelong damage to their child usually as a result of a simple mistake or omission. The complexity and number of factors in SCBU infants and the associated treatments that can affect NBS assays are challenging; and an even larger number of factors are not currently understood. This underscores a need for more consultation between neonatologists and NBS professionals. With the addition of more conditions to NBS panels and continuous advances and new treatments in SCBUs, the problem will only grow with time. It is advisable to have formal working relationships between NBS programs and neonatologists on the local level, and for neonatologists to be involved at the national and international level in advising on NBS policy issues. All NBS and SCBU staff urgently need to be educated about all the known factors, to implement SCBU standard protocols within screening jurisdictions, and to encourage research collaboration. This guideline does not attempt to address data systems in SCBUs that might facilitate implementation of this document. However, the document does recognize that more than one SCBU may be located in different cities, which could greatly enhance the complexity of implementation of laboratory information system (LIS) codes and procedures that should be uniform for all babies. Those professionals who work in NBS programs and SCBU units are well aware of the frequency of flagged results among these infants. Even with adjusted cutoffs, many if not most LBW infants have some abnormality on NBS that must be resolved. This results in more screening specimens, confirmatory testing, or both being ordered; the vast majority eventually provided false-positive results. Unfortunately, sensitivity and specificity of non DNA-based assays are inversely related, making it impossible to calibrate NBS assays to find no false-positive results, because this would greatly increase the probability of a false-negative finding, defeating the goal of NBS to find the maximum number of affected infants. As a result, approximately 2% to 10% of all NBS specimens are flagged as abnormal or the specimen itself is rejected for collection and handling problems. Of all abnormal NBS specimens, 10% to 40% belong to infants in SCBUs. With no standard protocol for screening or follow-up in this population, neonatologists and other nursery staff must cope with different recommendations that vary from program to program. Uniform recommendations crossing jurisdictional boundaries would perhaps increase adherence to them. This guideline represents a starting point for developing harmonious consensus with NBS programs and SCBUs worldwide, but consensus requires NBS programs to adopt and evaluate the guidelines and to recommend adjustments as necessary. It is very important to ensure that guidelines improve screening for SCBU infants and prevent infants from being missed. 3 Standard Precautions Because it is often impossible to know what isolates or specimens might be infectious, all patient and laboratory specimens are treated as infectious and handled according to standard precautions. Standard precautions are guidelines that combine the major features of universal precautions and body substance isolation practices. Standard precautions cover the transmission of all infectious agents and thus are more comprehensive than universal precautions, which are intended to apply only to transmission of blood-borne pathogens. Standard and universal precaution guidelines are available from the US Centers for Disease Control and Prevention. 15 For specific precautions for preventing the laboratory transmission of all infectious agents from laboratory instruments and materials and for recommendations for the management of exposure to all infectious diseases, refer to CLSI document M Clinical and Laboratory Standards Institute. All rights reserved.
11 Number 24 The Quality Management System Approach Clinical and Laboratory Standards Institute (CLSI) subscribes to a quality management system approach in the development of standards and guidelines, which facilitates project management; defines a document structure via a template; and provides a process to identify needed documents. The approach is based on the model presented in the most current edition of CLSI/NCCLS document HS01 A Quality Management System Model for Health Care. The quality management system approach applies a core set of quality system essentials (QSEs), basic to any organization, to all operations in any health care service s path of workflow (ie, operational aspects that define how a particular product or service is provided). The QSEs provide the framework for delivery of any type of product or service, serving as a manager s guide. The QSEs are Documents and Records Equipment Information Management Process Improvement Organization Purchasing and Inventory Occurrence Management Customer Service Personnel Process Control Assessment External and Internal Facilities and Safety addresses the QSEs indicated by an X. For a description of the other documents listed in the grid, please refer to the Related CLSI Reference Materials section on the following page. Documents and Records Organization Personnel Equipment Purchasing and Inventory Process Control X I/LA27 LA04 M29 Information Management Occurrence Management Assessment External and Internal Adapted from CLSI/NCCLS document HS01 A Quality Management System Model for Health Care. Path of Workflow A path of workflow is the description of the necessary steps to deliver the particular product or service that the organization or entity provides. For example, CLSI/NCCLS document GP26 Application of a Quality Management System Model for Laboratory Services defines a clinical laboratory path of workflow, which consists of three sequential processes: preexamination, examination, and postexamination. All clinical laboratories follow these processes to deliver the laboratory s services, namely quality laboratory information. addresses the clinical laboratory path of workflow steps indicated by an X. For a description of the other documents listed in the grid, please refer to the Related CLSI Reference Materials section on the following page. Examination ordering Process Improvement Customer Service Preexamination Examination Postexamination Sample collection Facilities and Safety Sample transport Sample receipt/processing Examination Results review and follow-up Interpretation Results reporting and archiving LA04 LA04 LA04 LA04 LA04 LA04 Adapted from CLSI/NCCLS document HS01 A Quality Management System Model for Health Care. Sample management M29 68 Clinical and Laboratory Standards Institute. All rights reserved.
12 Volume 29 Related CLSI Reference Materials I/LA27-A LA04-A5 Newborn Screening Follow-up; Approved Guideline (2006). This guideline describes the basic principles, scope, and range of follow-up activities within the newborn screening system. Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard Fifth Edition (2007). This document addresses the issues associated with specimen collection, the filter paper collection device, and the application of blood to filter paper, and provides uniform techniques for collecting the best possible specimen for use in newborn screening programs. M29-A3 Protection of Laboratory Workers From Occupationally Acquired Infections; Approved Guideline Third Edition (2005). Based on US regulations, this document provides guidance on the risk of transmission of infectious agents by aerosols, droplets, blood, and body substances in a laboratory setting; specific precautions for preventing the laboratory transmission of microbial infection from laboratory instruments and materials; and recommendations for the management of exposure to infectious agents. CLSI documents are continually reviewed and revised through the CLSI consensus process; therefore, readers should refer to editions. the most current Clinical and Laboratory Standards Institute. All rights reserved. 69
13 PL As we continue to set the global standard for quality in laboratory testing, we re adding initiatives to bring even more value to our members and customers. E Explore the Latest Offerings from CLSI! Power Forward with this Official Interactive Guide Fundamentals for implementing a quality management system in the clinical laboratory. The value of a CLSI membership begins with significant discounts up to 70% off on our trusted clinical laboratory standards and guidelines, but the benefits extend far beyond cost savings: Benefits to Industry Contribute to Standards that Streamline Product Review Processes Access a Deep Network of Customers, Peers, Regulators, and Industry Leaders Raise Your Organization s Profile in the Clinical Laboratory Community Benefits to Laboratories Directly Influence CLSI Standards to Ensure they are Practical and Achievable Access Globally Recognized Standards for Accreditation Preparedness Help Drive Higher Levels of Patient Care Quality All Over the World Benefits to Government Aid in the Development of Consensus Standards that can Impact Legislation Connect with Over 2,000 Influential Organizations Across the Global Laboratory Community Help Laboratories Provide Safe and Effective Care of the Highest Quality and Value About CLSI M The Clinical and Laboratory Standards Institute Visit the CLSI U Education Center SA Where we provide the convenient and cost-effective education resources that laboratories need to put CLSI standards into practice, including webinars, workshops, and more. Shop Our Online Products e CLIPSE TM Ultimate Access Including eclipse Ultimate Access, CLSI s cloud-based, online portal that makes it easy to access our standards and guidelines anytime, anywhere. Introducing CLSI s New Membership Opportunities (CLSI) is a not-for-profit membership organization that brings together the varied perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: to foster excellence in laboratory medicine by developing and implementing clinical standards and guidelines 950 West Valley Road, Suite 2500, Wayne, PA P: Toll Free (US): F: E: membership@clsi.org that help laboratories fulfill their responsibilities with efficiency, effectiveness, and global applicability. More Options. More Benefits. More Value. Join in Our Mission to Improve Health Care Outcomes We ve made it even easier for your organization to take full advantage of the standards resources and networking opportunities available through membership with CLSI. Find Membership Opportunities See the options that make it even easier for your organization to take full advantage of CLSI benefits and our unique membership value. For more information, visit today.
14 950 West Valley Road, Suite 2500, Wayne, PA USA P: Toll Free (US): F: ISBN E:
SAMPLE. Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions
4th Edition C24 Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions This guideline provides definitions, principles, and approaches to laboratory quality control
More informationSAMPLE. Use of Delta Checks in the Medical Laboratory
1st Edition EP33 Use of Delta Checks in the Medical Laboratory This guideline provides approaches for selecting measurands for which delta checks are useful, establishing delta check limits and rules for
More informationSAMPLE. Essential Tools for Implementation and Management of a Point-of-Care Testing Program
3rd Edition POCT04 Essential Tools for Implementation and Management of a Point-of-Care Testing Program This guideline provides direction to users of in vitro diagnostic devices outside the medical laboratory
More informationDIVISION OF PUBLIC HEALTH INFRASTRUCTURE, LABORATORIES AND
HEALTH 48 NJR 8(1) August 1, 2016 Filed July 8, 2016 PUBLIC HEALTH SERVICES BRANCH DIVISION OF PUBLIC HEALTH INFRASTRUCTURE, LABORATORIES AND EMERGENCY PREPAREDNESS PUBLIC HEALTH AND ENVIRONMENTAL LABORATORIES
More informationAlabama Newborn Screening
The Awards Issue! Alabama Newborn Screening September 2013 Volume 2, Issue 2 Alabama Department of Public Health 1-866-928-6755 Inside this issue: Alabama Hospitals Recognized for Quality Specimen Collection
More informationNewborn bloodspot screening
Policy HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited RACP, 145 Macquarie Street, Sydney NSW 2000, Australia
More informationNewborn Genetic Testing & Surveillance System
New Hampshire Newborn Genetic Testing & Surveillance System State NH Statute/ Rule STATUTE: Title X, Chapter 132:10-a to c RULE: Chapter He-P 3000 Language Specific to Genetic Testing and Surveillance
More informationMASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH POLICY ON THE RETENTION, STORAGE, AND USE OF NEWBORN SCREENING DATA AND RESIDUAL SPECIMENS DECEMBER 2015
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH POLICY ON THE RETENTION, STORAGE, AND USE OF NEWBORN SCREENING DATA AND RESIDUAL SPECIMENS DECEMBER 2015 I. Introduction II. Background III. Definitions IV. Rationale
More informationA SYSTEMATIC EVALUATION OF A NEWBORN SCREENING PROGRAM FOR SICKLE CELL DISEASE IN SOUTHERN GUJARAT, INDIA. Aishwarya Arjunan
A SYSTEMATIC EVALUATION OF A NEWBORN SCREENING PROGRAM FOR SICKLE CELL DISEASE IN SOUTHERN GUJARAT, INDIA by Aishwarya Arjunan BS Biology, Case Western Reserve University Submitted to the Graduate Faculty
More informationUpdating the National Newborn Screening Contingency Plan: Engaging Diverse Stakeholders and Families. Monday, March 6, :30 PM 5:30 PM
Updating the National Newborn Screening Contingency Plan: Engaging Diverse Stakeholders and Families Monday, March 6, 2017 4:30 PM 5:30 PM Learning Objectives Understand the purpose and benefit of newborn
More informationNewborn Screening: The Future Is Here
Newborn Screening: The Future Is Here Ed McCabe, MD, PhD Senior Vice President and Chief Medical Officer March of Dimes Foundation Overview NBS and the March of Dimes Advocacy for Improving NBS NBS Deserves
More informationNewborn Genetic Testing and Surveillance Systems
Patient Privacy and Public Trust: Newborn Genetic Testing and Surveillance Systems Copyright Citizens Council for Health Freedom August 2013 All state statutes and department rules accessed August 2012.
More informationInventory of Biological Specimens, Registries, and Health Data and Databases REPORT TO THE LEGISLATURE
Inventory of Biological Specimens, Registries, and Health Data and Databases REPORT TO THE LEGISLATURE MARCH 2017 1 Inventory of Biological Specimens, Registries, and Health Data and Databases February
More informationReports. Doing Good The Benefits of Volunteering for Your Life, Your Career, Your World. Melissa D Archangelo (CLSI, Wayne, PA)
Doing Good The Benefits of Volunteering for Your Life, Your Career, Your World Melissa D Archangelo (CLSI, Wayne, PA) DOI: 10.1309/LM6OM97FOAWUWKOT In today s fast-paced, plugged-in, sometimes impersonal
More informationQuality Indicators in Neonatal Medicine
Quality Indicators in Neonatal Medicine Potential collaborative research projects Imad MELKI M.D. NCPNN Quality Indicators: 1- An agreed-upon process or outcome measure that is used to determine the level
More informationMassachusetts Newborn Screening Public Health Service, Research and. Public Trust
Massachusetts Newborn Screening Public Health Service, Research and Anne Marie Comeau, Ph.D Deputy Director, New England Newborn Screening Program Professor of Pediatrics, UMMS 2016 APHL Annual Meeting
More informationClinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2
GUIDANCE AND RECOMMENDATIONS Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2 This document provides
More informationJOHNS HOPKINS HOSPITAL INPATIENT AND OUTPATIENT PEDIATRIC ENDOCRINOLOGY
JOHNS HOPKINS HOSPITAL INPATIENT AND OUTPATIENT PEDIATRIC ENDOCRINOLOGY YEAR 1 This experience provides the bulk of the training in clinical pediatric endocrinology. The fellow will attend the outpatient
More informationRecommendations for Implementing a World- Class State- of- the- Art Canadian Newborn Screening Programme
Recommendations for Implementing a World- Class State- of- the- Art Canadian Newborn Screening Programme Submitted by: Canadian Organization for Rare Disorders Durhane Wong- Rieger, PhD, President & CEO
More informationPediatric Endocrinology Elective PL-1 Residents
PL-1 Residents The Endocrinology elective is available to all interns for either a two-week or four-week time commitment. During this elective, interns will gain experience in both inpatient and outpatient
More informationThe Milestones provide a framework for assessment
The Medical Genetics Milestone Project The Milestones provide a framework for assessment of the development of the resident physician in key dimensions of the elements of physician competency in a specialty
More informationTo: Prefectural Governors From: Director General, Pharmaceutical and Food Affairs Bureau, Ministry of Health, Labour and Welfare
This draft English translation of notification on GLP has been made by JSQA. JSQA translated them with particular care to accuracy, but does not guarantee that there are no differences in the delicate
More informationI. Overall Goals and Objectives . Competencies
Page 1 Goals and Objectives Pediatric Endocrinology Fellowship Andrew Lane, MD Program Director Pediatric Endocrinology Department of Pediatrics Stony Brook University Children s Hospital Stony Brook,
More informationTo provide an integrated and coordinated approach to delivering Newborn Metabolic Screening (NMS) Program services to all infants born in Alberta.
TITLE NEWBORN METABOLIC SCREENING PROGRAM DOCUMENT # HCS-32 APPROVAL LEVEL Alberta Health Services Executive SPONSOR Population and Public Health CATEGORY Health Care and Services INITIAL APPROVAL DATE
More informationESSENTIAL NEWBORN CARE: INTRODUCTION
ESSENTIAL NEWBORN CARE: INTRODUCTION Essential Newborn Care Implementation Toolkit 2013 The Introduction defines Essential Newborn Care and provides an overview of Newborn Care in South Africa and how
More informationThe Persian Gulf Veterans Coordinating Board Fact Sheet
The Persian Gulf Veterans Coordinating Board Fact Sheet Persian Gulf Veterans' Health Problems An interagency board - the Persian Gulf Veterans Coordinating Board - was established in January 1994 to work
More informationNHS public health functions agreement Service specification no.19 NHS Newborn Blood Spot Screening Programme
NHS public health functions agreement 2017-18 Service specification no.19 NHS Newborn Blood Spot Screening Programme 2 NHS public health functions agreement 2017-18 Service specification no.19 NHS Newborn
More informationCYSTIC FIBROSIS FOUNDATION
CYSTIC FIBROSIS FOUNDATION Screening Improvement Program (SIP) for Optimizing the Diagnosis of Infants Award POLICIES AND GUIDELINES Published: January 17, 2018 Application Deadline: April 2, 2018 Cystic
More informationPEDIATRIC ENDOCRINOLOGY CLINICAL PRIVILEGES
Name: Page 1 Initial Appointment Reappointment All new applicants must meet the following requirements as approved by the governing body effective: 04/03/2013. Applicant: Check off the Requested box for
More informationRYAN WHITE HIV/AIDS PROGRAM SERVICES Definitions for Eligible Services
RYAN WHITE HIV/AIDS PROGRAM SERVICES Definitions for Eligible Services (Last Updated: July 15, 2013) Ryan White HIV/AIDS Program funds are intended to support only the HIV-related needs of clients. All
More informationTuberculosis: Surveillance and the Health Care Worker
Tuberculosis: Surveillance and the Health Care Jo Fagan Director Public Health PHAC Delivering a Healthy WA Overview 1. Pre-employment assessment 2. Post-exposure follow-up 3. Routine follow up testing
More informationClinical Laboratory Science Courses
Clinical Laboratory Science Courses 1 Clinical Laboratory Science Courses Courses CLSC 2111. Molecular Diagnostics Lab. This laboratory provides the basic skills necessary for performing and applying molecular
More informationNewborn Genetic Testing & Surveillance System
Oregon Newborn Genetic Testing & Surveillance System State OR Statute/ Rule STATUTE: ORS Title 36, Chapter 433 RULE: OAR Chapter 333 Language Specific to Genetic Testing and Surveillance System 433.285
More informationCLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success
CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success Jack Zakowski, PhD, FACB Director, Scientific Affairs and Professional Relations
More informationI. Rationale, Definition & Use of Professional Practice Standards
FRAMEWORK FOR STANDARDS OF PROFESSIONAL PRACTICE CONTENTS I. Rationale, Definition & Use of Standards of Professional Practice II. Core Professional Practice Expectations for RDs III. Approach to Identifying
More informationAmerican Health Information Management Association Standards of Ethical Coding
American Health Information Management Association Standards of Ethical Coding Introduction The Standards of Ethical Coding are based on the American Health Information Management Association's (AHIMA's)
More informationACOG COMMITTEE OPINION
ACOG COMMITTEE OPINION Number 365 May 2007 Seeking and Giving Consultation* Committee on Ethics ABSTRACT: Consultations usually are sought when practitioners with primary clinical responsibility recognize
More informationPatient Safety Course Descriptions
Adverse Events Antibiotic Resistance This course will teach you how to deal with adverse events at your facility. You will learn: What incidents are, and how to respond to them. What sentinel events are,
More informationStaffordshire, Shropshire & Black Country Newborn and Maternity Network. Neonatal Care Pathways 2015
Staffordshire, Shropshire & Black Country Newborn and Maternity Network Neonatal Care Pathways 2015 1 Introduction This is a revision to the original Staffordshire, Shropshire and Black Country Newborn
More informationP1: OTA/XYZ P2: ABC c01 BLBS040-Lorenz June 3, :34 Printer Name: Yet to Come CHAPTER ONE. The Problem-Oriented Approach. Michael D.
CHAPTER ONE The Problem-Oriented Approach Michael D. Lorenz During the 1960s, the problem-oriented medical record (POMR) was introduced in medical practice by Dr. Larry Weed. Dr. Weed developed a system
More informationInformed Disclosure & Consent for Care/Homebirth River & Mountain Midwives PLLC Susan Rannestad & Susanrachel Condon
Informed Disclosure & Consent for Care/Homebirth River & Mountain Midwives PLLC Susan Rannestad & Susanrachel Condon Please write in your own handwriting. Mother s name print your address, including zip
More informationSepsis in the NICU and Interventions to Improve Care
Sepsis in the NICU and Interventions to Improve Care Joseph El Khoury, MD Children s Hospital of Richmond at VCU Virginia Neonatal Perinatal Collaborative Meeting May 12 th, 2017 Significance of Sepsis
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationConflict of Interest
Newborn Screening in the NICU: A Process Improvement Initiative Allison Piques, NNP Conflict of Interest None to Disclose 1 Problem Statements Newborn Screens (NBS) are obtained at inconsistent times and
More informationInfection Control Manual. Table of Contents
This policy has been adopted by UNC Health Care for its use in infection control. It is provided to you as information only. Infection Control Manual Policy Name Patients with Cystic Fibrosis Policy Number
More informationThe Leapfrog Hospital Survey Scoring Algorithms. Scoring Details for Sections 2 9 of the 2017 Leapfrog Hospital Survey
The Leapfrog Hospital Survey Scoring Algorithms Scoring Details for Sections 2 9 of the 2017 Leapfrog Hospital Survey 2017 Leapfrog Hospital Survey Scoring Algorithms Table of Contents 2017 Leapfrog Hospital
More informationNursing Fundamentals
Western Technical College 10543101 Nursing Fundamentals Course Outcome Summary Course Information Description Career Cluster Instructional Level Total Credits 2.00 This course focuses on basic nursing
More informationPreparing and Registering S.T.A.B.L.E. Support Instructors
Preparing and Registering S.T.A.B.L.E. Support Instructors If a person is unable to attend an official National or Private Instructor course, but they wish to co-teach a S.T.A.B.L.E. Learner course with
More informationCertificate of Need (CON) Review Standards for NICU Beds & Special Newborn Nursery Services Effective March 3, 2014
+ Certificate of Need (CON) Review Standards for NICU Beds & Special Newborn Nursery Services Effective March 3, 2014 Northern Michigan Perinatal Summit July 23, 2014 Tulika Bhattacharya, CON Michigan
More informationCommunity Health Needs Assessment Joint Implementation Plan
Community Health Needs Assessment Joint Implementation Plan and Special Care Hospital CHNA-IP Report Page ii Community Health Needs Assessment (CHNA) Implementation Plan (IP) Report Table of Contents Introduction...
More informationPOSITIVELY AFFECTING NEONATAL OUTCOMES WORLDWIDE
POSITIVELY AFFECTING NEONATAL OUTCOMES WORLDWIDE Our network includes 1200+ centers across 30+ countries, collecting critical information on 2.5+ million infants and 72.5+ million patient days. 1 VERMONT
More informationMISSION, VISION AND GUIDING PRINCIPLES
MISSION, VISION AND GUIDING PRINCIPLES MISSION STATEMENT: The mission of the University of Wisconsin-Madison Physician Assistant Program is to educate primary health care professionals committed to the
More information2013 Mommy Steps. Program Description. Our mission is to improve the health and quality of life of our members
2013 Mommy Steps Program Description Our mission is to improve the health and quality of life of our members I. Purpose Passport Health Plan (PHP) has developed approaches to the management of members
More informationLibrary of Congress Cataloging-in-Publication Data
Library of Congress Cataloging-in-Publication Data Names: Reinisch, Courtney, editor. Nursing Knowledge Center, publisher. Title: Family nurse practitioner review and resource manual / edited by Courtney
More informationA Better Prescription for Reducing Medication Errors and Maximizing the Value of Clinical Decision Support
Clinical Drug Information A Better Prescription for Reducing Medication Errors and Maximizing the Value of Clinical Decision Support Medication errors are defined as preventable events that occur during
More informationHow to Improve the Laboratory Experience CLS and MLT Working Together
How to Improve the Laboratory Experience CLS and MLT Working Together Dora W. Goto, MS, CLS, MLS(ASCP) CM California Association for Medical Laboratory Technology Immediate Past President Fremont, CA September
More informationExecutive Report to the European Commission on newborn screening in the European Union
EU Tender Evaluation of population newborn screening practices for rare disorders in Member States of the European Union Executive Report to the European Commission on newborn screening in the European
More informationManager. 2. To establish procedures for selecting and acquiring biomedical equipment.
Page 1 of 8 CENTRAL STATE HOSPITAL POLICY SUBJECT: BIOMEDICAL EQUIPMENT MANAGEMENT ANNUAL REVIEW MONTH: RESPONSIBLE FOR REVIEW: October Regional Safety & Environmental Health Manager LAST REVISION DATE:
More informationPerformance of Point-of-Care Testing in Unaccredited Settings:
Performance of Point-of-Care Testing in Unaccredited Settings: A Guideline for Non-Laboratorians Prepared by the Advisory Committee on Laboratory Medicine College of Physicians & Surgeons of Alberta You
More informationThe CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI
The CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI Today s Topics and Goals Introduction to CLSI The consensus process: a primer
More informationHuman Milk. Neonatal Nursery Policy & Procedures Manual Policy Group: GI/GU Date Approved August 2012 Next Review August Approved by: Purpose
Approved by: Gail Cameron Director, Maternal, Neonatal & Child Health Programs Human Milk Neonatal Nursery Policy & Procedures Manual : August 2012 Next Review August 2015 Dr. Ensenat Medical Director,
More informationNeonatal Intensive Care Unit (NICU) Level of Care Authorization and Reimbursement Policy
In the event of conflict between a Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern. Plan documents include,
More informationTips and Tools for Learning Improvement. Developing Changes
Tips and Tools for Learning Improvement Developing Changes What are changes in improvement? Making improvement requires change. Changes are any possible solutions to problems identified by improvement
More informationNursing Complex Health Alterations 1
Western Technical College 10543109 Nursing Complex Health Alterations 1 Course Outcome Summary Course Information Description Career Cluster Instructional Level Total Credits 3.00 Complex Health Alterations
More informationThe deadline for submitting an application is September 6, 2018.
July 2, 2018 Dear Florida Hospital Leaders, It s with great enthusiasm we invite you to participate in the Florida Perinatal Quality Collaborative (FPQC) initiative for Neonatal Abstinence Syndrome (NAS)
More informationState of Minnesota HOUSE OF REPRESENTATIVES EIGHTY-EIGHTH SESSION
This Document can be made available in alternative formats upon request State of Minnesota HOUSE OF REPRESENTATIVES EIGHTY-EIGHTH SESSION H. F. No. 589 02/14/2013 Authored by Kahn, Huntley, Norton, Holberg
More informationGuide to Incident Reporting for In-vitro Diagnostic Medical Devices
Guide to Incident Reporting for In-vitro Diagnostic Medical Devices SUR-G0004-4 02 AUGUST 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationThe Practice Standards for Medical Imaging and Radiation Therapy. Radiography Practice Standards
The Practice Standards for Medical Imaging and Radiation Therapy Radiography Practice Standards 2017 American Society of Radiologic Technologists. All rights reserved. Reprinting all or part of this document
More informationCPQCC. California Perinatal Quality Care Collaborative DESIGN AND ACCOMPLISHMENTS JEFFREY B. GOULD, MD, MPH
CPQCC California Perinatal Quality Care Collaborative DESIGN AND ACCOMPLISHMENTS 1997-2015 JEFFREY B. GOULD, MD, MPH DIRECTOR, PERINATAL EPIDEMIOLOGY AND OUTCOMES UNIT DEPARTMENT OF PEDIATRICS STANFORD
More informationEuropean IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals
European IVD Regulations and Risk Based Classification An Overview for Global Quality Professionals Anna Sadio IVD Technical Expert/Project Manager Oct 2013 Caution The new regulations are draft and subject
More informationInstant results with a simple touch
Instant results with a simple touch BiliChek noninvasive bilirubin assessment tool Assessing risk and improving care Introducing the new BiliChek. Our innovation gives you the most advanced transcutaneous
More informationThe Future is Now: Global Application of CLSI and ISO:15189 Quality Management Systems
The Future is Now: Global Application of CLSI and ISO:15189 Quality Management Systems Executive War College May 5, 2009 Glen Fine, MS, MBA Executive Vice President, CLSI Key Discussion Points Upon completion
More informationPhlebotomy Technician Syllabus/Course Curriculum
Phlebotomy Technician Syllabus/Course Curriculum Program Information Hours: 80 Hours Course Length Access: 2 Weeks Program Description Phlebotomy Technician program is designed to teach the knowledge in
More informationTHE ACD CODE OF CONDUCT
THE ACD CODE OF CONDUCT This Code sets out general principles in relation to the practice of Dermatology. It is not exhaustive and cannot cover every situation which might arise in professional practice.
More informationWolf EMR. Enhanced Patient Care with Electronic Medical Record.
Wolf EMR Enhanced Patient Care with Electronic Medical Record. Better Information. Better Decisions. Better Outcomes. Wolf EMR: Strength in Numbers. Since 2010 Your practice runs on decisions. In fact,
More informationAssignment 2: KMC Global: Ghana
Assignment 2: KMC Global: Ghana Ghana o Household About 1/3 are women 40% of Ghanaian population is under age 15 Families often live with extended family members Tradition of either move in to live with
More informationFAST. A Tuberculosis Infection Control Strategy. cough
FAST A Tuberculosis Infection Control Strategy FIRST EDITION: MARCH 2013 This handbook is made possible by the support of the American people through the United States Agency for International Development
More informationPART IIIB DIPLOMA AND CERTIFICATE PROGRAMS CURRICULA
PART IIIB DIPLOMA AND CERTIFICATE PROGRAMS CURRICULA NURSE EDUCATION DEPARTMENT Practical Nurse Education Program (Diploma Program) Objective This professional education program is designed to provide
More informationLAW OF GEORGIA ON PATIENT RIGHTS
LAW OF GEORGIA ON PATIENT RIGHTS Chapter I. General Provisions Article 1 The purpose of this Law is to protect the rights of citizens to receive healthcare, as well as to ensure inviolability of their
More informationRegistered Midwife. Location : Child Women and Family Division North Shore and Waitakere Hospitals
Date: November 2017 Job Title : Registered Midwife Department : Maternity Service Location : Child Women and Family Division North Shore and Waitakere Hospitals Reporting To : Charge Midwife Manager for
More informationCalifornia Children s Services (CCS) Redesign Medical Eligibility
California Children s Services (CCS) Redesign Medical Eligibility Robert Dimand, MD Chief Medical Officer California Children s Services Systems of Care Division, Department of Healthcare Services - 1
More informationOBSTETRICAL ANESTHESIA
DEPARTMENT OF ANESTHESIA RESIDENCY TRAINING PROGRAM UNIVERSITY OF MANITOBA OBSTETRICAL ANESTHESIA INTRODUCTION Residents will have the opportunity to gain experience in Obstetrical anesthesia in the course
More informationNational EMS Scope of Practice Model Revision 2018
1 2 3 4 5 6 National EMS Scope of Practice Model Revision 2018 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 THIS VERSION CONTAINS TWO PARTS: I. EMS LEVEL DESCRIPTIONS II. RAPID PROCESS FOR
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More information2017 APHL BIOSAFETY AND BIOSECURITY SURVEY
2014 APHL All Hazards Laboratory Preparedness Survey 2017 APHL BIOSAFETY AND BIOSECURITY SURVEY SUMMARY DATA REPORT April 2018 Introduction The 2017 APHL Biosafety and Biosecurity Survey was launched on
More informationNational Patient Safety Goals Effective January 1, 2016
National Patient Safety Goals Effective January 1, 2016 Goal 1 Improve the accuracy of patient identification. NPSG.01.01.01 Home are Accreditation Program Use at least two patient identifiers when providing
More informationQC Explained Quality Control for Point of Care Testing
QC Explained 1.0 - Quality Control for Point of Care Testing Kee, Sarah., Adams, Lynsey., Whyte, Carla J., McVicker, Louise. Background Point of care testing (POCT) refers to testing that is performed
More informationORIGINAL ARTICLE. Prevalence of nonmusculoskeletal versus musculoskeletal cases in a chiropractic student clinic
ORIGINAL ARTICLE Prevalence of nonmusculoskeletal versus musculoskeletal cases in a chiropractic student clinic Bruce R. Hodges, DC, MS, Jerrilyn A. Cambron, DC, PhD, Rachel M. Klein, DC, Dana M. Madigan,
More informationNURSE PRACTITIONER STANDARDS FOR PRACTICE
NURSE PRACTITIONER STANDARDS FOR PRACTICE February 2012 Acknowledgement The College of Registered Nurses of Prince Edward Island gratefully acknowledges permission granted by the Nurses Association of
More informationMedicaid Covered Services Not Provided by Managed Medical Assistance Plans
Medicaid Covered Services Not Provided by Managed Medical Assistance Plans This document outlines services not provided by MMA plans, but are available to Medicaid recipients through Medicaid fee-for-service.
More informationWEEK DAY LECTURE SUBJECTS CLASS HOURS ORIENTATION. Course Logistics: breaks; schedule etc.
WEEK DAY LECTURE SUBJECTS CLASS HOURS 1 1 ORIENTATION Course Logistics: breaks; schedule etc. Course Overview: review syllabus, assignment, quizzes, recitation NCLEX Test plan and format; How to study;
More informationGuidelines for Pediatric Cardiology Diagnostic and Treatment Centers
Section on Cardiology Guidelines for Pediatric Cardiology Diagnostic and Treatment Centers This document describes the clinical and physical environment in which infants and children with heart disease
More informationNURSING COMPUTER SOFTWARE. Level 2- Semester 4. Advanced Medical Surgical Nursing/ Clinical Lab
NURSING COMPUTER SOFTWARE Level 2- Semester 4 Nur 1210/ 1210L Advanced Medical Surgical Nursing/ Clinical Lab RECOMMENDED FOR ALL COURSES: Successful Test- taking Tips for Windows: (Copyright 1998) Test-Taking
More informationResponsibilities of Public Health Departments to Control Tuberculosis
Responsibilities of Public Health Departments to Control Tuberculosis Purpose: Tuberculosis (TB) is an airborne infectious disease that endangers communities. This document articulates the activities that
More informationOrganization Review Process Guide Perinatal Care Certification
Organization Review Process Guide Perinatal Care Certification 2016 Perinatal Care Certification Review Process Guide for Health Care Organizations 2016 What s New? Review process and contents of this
More informationOrganization: Adventist Healthcare Shady Grove Medical Center
Organization: Adventist Healthcare Shady Grove Medical Center Title: A Team-Based, Innovative Approach to Providing Safer Care by Reducing the Incidence of Chronic Lung Disease in the Premature Newborn
More informationManaging Programmes to Improve Child Health Overview. Department of Child and Adolescent Health and Development
Managing Programmes to Improve Child Health Overview Department of Child and Adolescent Health and Development 1 Outline of this presentation Current global child health situation Effective interventions
More informationThe Practice Standards for Medical Imaging and Radiation Therapy. Limited X-Ray Machine Operator Practice Standards
The Practice Standards for Medical Imaging and Radiation Therapy Limited X-Ray Machine Operator Practice Standards 2017 American Society of Radiologic Technologists. All rights reserved. Reprinting all
More informationGuideline for Supporting Healthy Pregnancy at Work
Guideline for Supporting Healthy Pregnancy at Work Contents Statement of Purpose:... 1 Roles and Responsibilities:... 2 Risk Identification and Assessment... 4 Risk Controls... 5 Written Safe Work Procedures...
More information